Hable con su médico acerca de la PrEP
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Hable con su médico acerca de la PrEP
  • Published Date:

    4/23/2014

  • Language:
    Spanish
Filetype[PDF-336.70 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 467.16 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    5/13/2014
    Description:
    Are you HIV negative but worry you might become positive? Take charge – talk to your doctor about PrEP.CS247902-A
    File Type:
    Filetype[PDF - 467.16 KB]
  2. Filetype[PDF - 1.47 MB]
    Personal Author:
    Heneine, Walid; Thompson, Melanie; Smith, Dawn K.; Iskander, John K.; Thorpe, Phoebe; Laird, Susan;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication.. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention
..
    Published Date:
    May 20, 2014
    Source:
    Public health grand rounds ; 2014 April 22
    Description:
    An estimated 50,000 individuals become infected with the human immunodeficiency virus (HIV) in the United States annually. A new prevention strategy, Pre-exposure Prophylaxis (PrEP), is intended for high-risk populations to reduce their risk of becom...
    File Type:
    Filetype[PDF - 1.47 MB]
  3. Filetype[PDF - 98.02 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    8/26/11
    Description:
    Daily oral PrEP with a tablet containing tenofovir disoproxil fumarate and emtricitabine (TDF/FTC, known by the brand name Truvada®) was found to reduce the risk of acquiring HIV infection by roughly 63 percent in the study population overall.In add...
    File Type:
    Filetype[PDF - 98.02 KB]
  4. Filetype[PDF - 1.49 MB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Act Against Aids.
    Published Date:
    2/17/2017
    Series:
    Act Against AIDS
    Start Talking. Stop HIV.
    Description:
    The conversation about HIV is changing. There are more HIV prevention options than ever before. Start talking about testing, your status, condoms, PrEP, and medicines that treat HIV.
    File Type:
    Filetype[PDF - 1.49 MB]
  5. Filetype[PDF - 4.46 MB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Act Against Aids.
    Published Date:
    5/19/15
    Series:
    Are you ready for PrEP?
    Start Talking. Stop HIV.
    Act against AIDS
    Description:
    stsh_prep-ig2_v5Publication date from document properties.
    File Type:
    Filetype[PDF - 4.46 MB]